Efficacy of Using Mobile Health Applications for Health
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Mobile health application.
- Who it may be relevant to
- Registry conditions: Diabetes Mellitus, Type 2, Obesity. Basic parameters: 18 years — 64 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and type II diabetes outcomes in type 2 diabetics. This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the same time, and check their blood glucose readings daily before and after meals for at least three meals in the day.
Interventions
- Other Mobile health application
Intervention will be with mobile health application
Primary outcome measures
- Effectiveness of mHealth apps at changing bodyweight assessed by bodyweight measurements over 6 months [Time frame: 6 months]
- Self-efficacy in weight management assessed by Weight Management and Nutrition Knowledge questionnaire [Time frame: 6 months]
- Long term change in diabetes via A1c [Time frame: 6 months]
- Long term change in diabetes via fasting blood glucose [Time frame: 6 months]
Secondary outcome measures (1)
- Quality of Life after using mHealth apps assessed by World Health Organization Quality of Life BREF questionnaire [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- Diagnosed with type II diabetes for at least 3 months
- Between the age of 18-64
- BMI ≥ 25
- Monitors blood glucose regularly (at least once per day)
- Owns or has access to a bathroom weight scale
- Owns a smartphone and willing to download mobile app
Exclusion criteria
- Does not check blood glucose at least once per day
- On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications.
Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are oka
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
United States · 1 center
- San Diego State University — San Diego
Identifiers
NCT: NCT05589155 · HS-2022-0156